Option update: GlaxoSmithKline volatility flat following earnings warning

Posted Feb 7th 2008 10:26AM by Paul FosterPaul Foster RSS Feed
Filed under: Earnings Reports, Options

More

GlaxoSmithKline (NYSE: GSK) is recently down $3.75 to $42.13.

GSK reported a declining Q4 pre-tax profit and warned 2008 earnings will be negatively affected by decreasing sales of diabetes drug Avandia, competition from generics and a weak dollar.

GSK overall option implied volatility of 26 is near its 26-week average according to Track Data, suggesting non-directional risk.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Tags: GlaxoSmithKline, gsk, inthenews, option implied volatility, OptionImpliedVolatility

Symbol Lookup
IndexesChangePrice
DJIA-37.1910,741.98
NASDAQ-16.872,374.41
S&P 500-5.921,159.90

Last updated: March 20, 2010: 08:17 AM

Hot Stocks

General Electric

18.07-0.12(-0.66)

Alcoa

14.26-0.04(-0.28)

Apple Inc

222.2499-2.4001(-1.07)

Google Inc 'A'

560.00-6.40(-1.13)

Bank of America

16.82-0.26(-1.52)

Wal-Mart Stores

55.34-0.60(-1.07)

Exxon Mobil Corp

67.04-0.35(-0.52)

Ford

13.29-0.44(-3.20)

Citigroup

3.90-0.12(-2.99)

IBM

127.71-0.67(-0.52)

Yahoo

16.44-0.12(-0.72)

Starbucks

24.97-0.05(-0.20)

Microsoft

29.59-0.02(-0.07)

Home Depot

32.36-0.04(-0.12)

DailyFinance Headlines

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    • My Portfolio
    • Create a New Portfolio

    BloggingStocks Partners

    More from AOL Money & Finance

    WalletPop Headlines